Lorillard
Statement of Duncan Hutcheon, M.D., D.Phil. Departments of Pharmacology and Medicine 820312
Fields
- Author
- Hutcheon, D.
- Alias
- 03608016/03608021
- Type
- SPCH, SPEECH/PRESENTATION
- Area
- LEGAL DEPT FILE ROOM
- Site
- N14
- Named Organization
- NIH, Natl Inst of Health
- Nj Medical School
- Princeton Inst
- Nj Medical School
- Named Person
- Hutcheon, D.
- Date Loaded
- 07 Jan 1999
- Master ID
- 03607523/8364
Related Documents:- 03607523-8364 Comprehensive Smoking Prevention Education Act of 810000 Hearing Before the Committee on Labor and Human Resources United States Senate Ninety-Seventh Congress Second Session on S. 1929
- 03607531-7540 97th Congress 1st Session S. 1929 to Amend the Public Health Service Act and the Federal Cigarette Labeling and Advertising Act to Increase the Availability to the American Public of Information on the Health Consequences of Smoking and Thereby Improve Informed Choice, and for Other Purposes.
- 03607587-7594 National Institute on Drug Abuse Technical Review on Cigarette Smoking As An Addiction
- 03607618-7620 Coaliion on Smoking or Health Seeks to Influence Legislators
- 03607621-7623 Coalition on Smoking or Health .. A Public Policy Project with the National Interagency Council on Smoking and Health
- 03607624-7626 Former Ftc Counsel to Staff Coalition on Smoking or Health
- 03607627-7629 Statement of the American Lung Association to the House Subcommittee on Health and the Environment on H.R. 5653, the Comprehensive Smoking Prevention Education Act
- 03607630-7636 the Importance of the Federal Government in the Prevention of Smoking Related Diseases Testimony in Support of H.R. 5653, A Revised Version of H.R. 4957 the Comprehensive Smoking Prevention Education Act by the American Lung Association
- 03607681-7692 Lung Cancer, Coronary Heart Disease and Smoking
- 03607705-7710
- 03607717-7724 Statement on S. 1929 'comprehensive Smoking Prevention Education Act of 810000' of Dan G. Mcnamara, M.D., F.A.C.C. President to Honorable Orrin G. Hatch Chairman Committee on Labor and Human Resources
- 03607725-7726 File No. 792-3204
- 03607727-7730 Statement of the American Medical Association to the Labor and Human Resources Committee U.S. Senate Re: S. 1929 Comprehensive Smoking Prevention Education Act
- 03607731-7734 Statement on S. 1929 the Comprehensive Smoking Prevention Education Act of 810000 by John R. Walton, Rrt President
- 03607735-7740 Statement of the American College of Physicians on S. 1929, the 'comprehensive Smoking Prevention Education Act of 810000'
- 03607741-7749 Testimony of the American College of Chest Physicians Submitted by Thomas L Petty, M.D., F.C.C.P. President Regarding S. 1929 'the Comprehensive Smoking Prevention Education Act of 820000'
- 03607750-7751 Testimony of Action on Smoking and Health (Ash), by Its Executive Director and Chief Counsel, John F, Banzhaf III, Before the Senate Committee on Labor and Human Resources, Chaired by the Honorable Orrin G. Hatch, on the Comprehfnsive Smoking Prevention Education Act (S. 1929) Submitted 820402
- 03607752-7763 Federal Trade Commission Staff Report on the Cigarette Advertising Investigation
- 03607764-7770 Statement of the Bakery, Confectionery & Tobacco Workers International Union to the Senate Committee on Labor and Human Resources Re: S. 1929 'the Comprehensive Smoking Prevention Education Act of 820000
- 03607771-7790 Comments on H.R. 4957 - - Proposed 'comprehensive Smoking Prevention Education Act of 810000'
- 03607791-7793 Cigarette Smoking of Pregnant Women
- 03607794-7809 Peter L. Berger
- 03607810-7813 Gilgamesh on the Washington Shuttle
- 03607814-7848 Statement Rodger L. Bick, M.D.
- 03607849-7854 Statement of Theodore H. Blau Ph.D. Presented Before Subcommittee on Health and the Environment House of Representatives
- 03607855-7858 Statement of Walter M. Booker, Ph.D.
- 03607859-7864 Statment Smoking and Fetal Growth
- 03607865-7873 Curriculum Vitae Oliver Gilbert Brooke
- 03607874-7884 Statement of Barbara B. Brown, Ph.D.
- 03607885-7892 Statement of Dr. Victor Buhler
- 03607893-7896 Statement of Jack Matthews Farris, M.D.
- 03607897-7909 Statement of Sherwin J. Feinhandler, Ph.D.
- 03607910-7936 Statement of Edwin R. Fisher, M.D.
- 03607937-7945 Statement of H. Russell Fisher, M.D.
- 03607946-7979 Statement of Jean D. Gibbons
- 03607980-7983 Statement of Katherine Mcdermott Herrold, M.D.
- 03607984-7997 Statement of Arthur Furst, Ph.D.
- 03607998-8015 Statement of Richard J, Hickey, Ph.D.
- 03608022-8053 Statement of Leon O. Jacobson
- 03608054-8065 State Ment of Lawrence L, Kupper, Ph.D.
- 03608066-8085 Statement of Hiram Thomas Langston M.D. Clinical Professor of Surgery (Emeritus) Northwestern University Medical School
- 03608086-8091 the Alleged Cost of Cigarette Smoke
- 03608092-8121 Statement of Eleanor J. Macdonald Professor Emeritus of Epidemiology Department of Cancer Prevention University of Texas System Cancer Center M.D. Anderson Hospital and Tumor Institute, Houston, Texas
- 03608122-8129 Statement of John E. O'toole, Chairman, Foote, Cone & Belding Communications, Inc.
- 03608130-8166 Statement by L.G.S. Rao, Ph.D. Bellshill Maternity Hospital Bellshill, Scotland, U.K. Regarding H.R. 4957 S. 1929
- 03608167-8169
- 03608170-8173 Statement of Henry Rothschild, M.D., Ph.D.
- 03608174-8176
- 03608177-8190 Statement of Bernice C. Sachs, M.D., Seattle, Washington
- 03608191-8195 Concerning the 'comprehensive Smoking Prevention Act of 820000'
- 03608196-8204
- 03608205-8236 Statement of Sheldon C. Sommers, M.D.
- 03608237-8246 Statement Professor T.D. Sterling
- 03608247-8275 Statement of Professor Yoram J. Wind for Submission to the Subcommittee on Health and the Environment
- 03608276-8277 for Use at 10 A.M. Tuesday, 820316
- 03608278-8287 Statement of Robert Casad Hockett
- 03608288-8317 Relationships Between Family Smoking Habits, Individual Differences in Personality, and the Smoking Behavior of College Students
- 03608318-8337 Personality and Smoking Behavior
- 03608338-8364 on the Relation Between Family Smoking Habits and the Smoking Behavior of College Students
- Author (Organization)
- College of Medicine + Dentistry Nj
- Litigation
- Ppla/Produced
- Characteristic
- EXTR, EXTRA
- UCSF Legacy ID
- tkv99d00
Document Images
495
~ .
COLLEGE OF MEDICINE AND DENTISTRY OF NEW JERSEY
NEW JERSEY MEDICAL SCHOOL
100 Beqen Street
Newark, New Jersey 07103
Statement
of
Duncan Hutcheon, M.D., D.Phil.
Depaztmenta of Pharmacology and Medicine
March 12, 1982
Tb. CWq..f MqlcM. a D.s*vy d M.. 1nry Y...wul .ooiroNtr =Ms.nrny,MM.uw acn~ .VM.rv

i
496
My name is Duncan Hutcheon. I am Professor of Pharma-
cology and Medicine at the College of Medicine and Dentistry of
New Jersey. I am also an attending physician at the College
Hospital in Newark and am director of the Clinical Pharmacology
Training Program at the New Jersey Medical School, where my
responsibilities have included serving on the Human Studies
Research Committee. I am a graduate of the University of Toronto
where I received my M.D. and B.Sc.(Med.) degrees. In ]950, as a
National Research Council (Canada) Postdoctoral Fellow, I
obtained my Ph.D. at Oxford University in the Department of
Pharmacology.
My research has been primarily in the field of cardio-
vascular and clinical pharmacology, and I have approximately 65
research publications. In addition, I have contributed sections
of several textbooks, including Drill's Pharmacology and Medicine,
Treatment of Heart Disease in the Adult by Rubin, et al., and
Cardiovascular Therapy by Russek. Since ]977, I have served as
editor of the Journal of Clinical Pharmacology.
I hold memberships in numerous medical and scientific
societies including the American Society for Pharmacology and
Experimental Therapeutics and the Society for Experimental Biology
and Medicine. I am a fellow of the American College of
497
Physicians and the American College
which I am a past-president.
In May, 1980, I helped esta
of Environmental Medicine (PIEM), a:
scientists concerned about the healt
stances in the environment. Our res
the relationship between various env:
c^ronic diseases such as heart diseas
-enta1 factors we are investigating i
_..ts, industrial chemicals, pesticide
=ie=e1, and gasoline engines.
It is the consensus of thce
-- the institute that it is
iapossibl
:al statements about the contribution
.ccu_rence of cancer and heart diseas
::e statements in H.R. 4957 and S. 19
economic consequences of smoking are
t:.d appear to represent an attempt t
++':at are actually complex multifacetec
Furthermore, it is our bel:
"onsibility of encouraging thoroug:
--_o the spectrum of risk factors ass,
-2-.
.'t

497
Physicians and t_: Axrican College of Clinical Pharmacology of
vhich I am a pas_-w esicent.
In Ma:, :95C, I helped establish the Princeton Institute
of Environmenta: !ledicine (PIEM), an organization of medical
scientists cor.ce ^ed about the health effects of chemical sub-
stances in the ewiro:.aent. Our research focuses primarily on
the relationshi= bets,een various environmental risk factors and
chronic diseases sueA as heart disease and cancer. The er.viron-
mental factors we are investigating include tobacco smoke constitu-
ents, industr:a: c.hezLicals, pesticides, and emissions from jet,
diesel, and gascliae engines.
It is the consensus of those associated with the work
o= the Institu:e that it is impossible to make strong, unecaivo-
;al statements abcut tY:e contribution of any single factor to the
occurrence of ea+zcer and heart disease. . For this reason, many o:
the statements in R.R. 4957 and S. 1929 regarding the health and
economic consec^uences of smoking are unacceptable scientifically
and appear to :epresent an attempt to offer easy solutions to
what are actually complex multifaceted problems.
Fur-thermore, it is our belief that Congress has the
responsibility of encouraging thorough and unbiased investigation
into the spect.-um of risk factors associated with these diseases
-2-.

498
rather than limiting its consideration to only one aspect. Why,
for example, doesn't the proposed legislation mention environmental
hazards? After all, in terms of both quantity and inherent carcino-
genicity and cardiotoxicity, environmental chemicals such as
polycyclic hydrocarbons (PAB's), halogenated hydrocarbon pesti-
cides and industrial solvents appear to pose serious public health
problems.
- These views are based on our field work that involves
correlating mortality data provided by the National Institutes of
Eealth with our own clinical and laboratory findings. By this
method, we have examined the following environmental pollutants:
benzo(a)pyrene (BaP) and other PAH's, carbcrn monoxide (CO), and
halogenated hydrocarbon pesticides and industrial solvents.
our studies show that there is considerable misinfor-
mation regarding the possible biologic effects of the various
chemicals to which we are regularly exposed. Moreover, there is
little appreciation of the way in which such substances are handled
by the body (i.e., how and when they
are eliminated), and the
relationship between the amounts of chemicals present in the
environment and the amounts necessary to initiate carcinogenic
and cardiotoxic activity.
-3-
499
For example, we measured serum B(a:
immunoassay procedure in urban and suburban
F
the New York metropolitan area and found si,
levels in the group living in the areas with
pollution. B(a)P was chosen as a marker of
because it is a suspected carcinogen that is
fossil fuels. It is also considered to be a
potentially carcinogenic PAH's in the atmos-
rations indicate that geographic location me
-_s:; factor for respiratory cancer. While th
...-y preliminary findings, they suggest that
_::cu_d be conducted on a much larger scale.
ass:st in identifying pcpulations at enviror.rr
pci.^.tinc geocraphic areas where enviro:.mentz
>:cu:d be directed.
.During the past three years, my le
focused on the effects of environmental che
performar.ce. This haa involved investigatir
-etween geographic location and the prevalen
a.1d sudden cardiac death. Our findings suc
c:eaicals associated with adverse cardiologic
both in the ambient air over Newark and in
SupP1Y of suburban communities. The chemica:
-4-

1:
11
0
499
For example, we measured serum B(a)P levels by radio-
i,=unoassay procedure in urban and suburban population groups in
the New York metropolitan area and found significantly higher
levels in the group living in the areas with highest atmospheric
pollution. B(a)P was chosen as a marker of urban air pollution
because it is a suspected carcinogen that is produced by burning
fossil fuels. It is also considered to be a valid indicator of
pctentially carcinogenic PAB's in the atmosphere. Our obser-
vations indicate that geographic location may be an important
ris:: factor for respiratory cancer. While these results represent
only prelir:.inary findings, they suggest that environmental studies
s::sLld be conducted on a much larger scale. Such studies could
assist in identifying populations at environmental risk and pin-
oci-lting geographic areas where enviro^-nental control efforts
s:culd be cirected.
.During the past three years,.my laboratory has also
focused cn the effects of environmental chemicals on cardiac
performance. This has involved investigating the association
between geographic location and the prevalence of heart disease
hnd sudden cardiac death. Our findings suggest that certain
chemicals associated with adverse cardiologic effects are present
both in the ambient air over Newark and in the drinking water
supply of suburban communities. The chemical agents that may be'
-4-

500
related to cardiac mortality rates in areas of greatest risk are
the halogenated hydrocarbons.
Although we originally assumed that CO might play some
role in heart disease causation, our findings have suggested that"-`
...;..?grf _.
(1) CO does not appear to predispose the heart to catecholamine-
induced arrhythmias in experimental animals; and (2) although the `~
CO levels are higher in the ambient air in the urban-industrial °~
wetien of Newark than in the New York suburbs, the concentrations
do not seem high enough to cause health consequences.
Our laboratory studies have also led us to an appreci-
ation of the importance of the absorption/elimination characte-
ristics of environmental chemicals. It is our view that the
toxic properties of foreign chemicals ultimately depend on how
well the body biotransforms and eliminates them and on how the
body's i=mmunological and other defense systems operate. It is
clearly evident that more research is needed on the health effects
of long-term, low level exposure to chemicals.
In.summary,-our work at PIEM indicates that a balanced
scientific approach is necessary in the study of the health con- -
sequences of environmental risk factors. Any approach that
limits its consideration to only one factor, like tobacco smoke,
will hinder the generation and analysis of the epidemiological,
pharmacokinetic, and toxicologic data needed to effectively study
the causes of our nation's health problems.
STATEMENT OF LEON O. JA
: 3m Leon Orris Jacobson from The Uni%
i_t3o where I continue as a physician-s<
t:- served as Chairman of Medicine, Dean
and Di rector o f the Argonne Cance
?ebruary 1942 I became responsible for
e personnel of the Metallurgical Laborat
_-ct) under the direction of Arthur Ooa
_rry, Enrico Fermi, Leon Szilar3 and
-,ed the first self-sustaining chain r
^-'. 3s Associate Director and then Dire
-:y of this enormously successful nati
t the war abruptly to an end and in
the technology and the radioisoto
'-'^ sLy important to the revolutionary
:ciae that contribute an ever inere
^r3t3niing of normal as well as disease
zed the Scientific A3visory Board
+':v Research Committee (now called th
U.S.A. , Inc. ) in 1954 when it -
of Clarence Coo!c Little. Dr. L
''"'"-3sional committees dealing with smok:
snI L9G9. The mandate of the Scienti:
3nd simple, namely to sponsor inc
